End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
273.00 TWD | -0.55% |
|
-0.55% | -2.50% |
07-07 | Topco Scientific Unit Bags Construction Deal | MT |
05-05 | Topco Scientific Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 | CI |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 6.27 | 6.84 | 7.33 | 6.5 | 7.15 | |||||
Return on Total Capital | 10.5 | 11.52 | 13.19 | 10.97 | 11.49 | |||||
Return On Equity % | 20.53 | 20.48 | 24.46 | 19.94 | 21.98 | |||||
Return on Common Equity | 20.6 | 20.7 | 24.58 | 20.2 | 22.24 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 11.9 | 12.22 | 12.32 | 13.03 | 13.54 | |||||
SG&A Margin | 5.93 | 6 | 5.93 | 6.27 | 6.51 | |||||
EBITDA Margin % | 6.27 | 6.6 | 6.7 | 7.16 | 7.48 | |||||
EBITA Margin % | 5.74 | 6.08 | 6.23 | 6.64 | 7.03 | |||||
EBIT Margin % | 5.7 | 5.98 | 6.1 | 6.49 | 6.92 | |||||
Income From Continuing Operations Margin % | 5.71 | 5.39 | 5.8 | 5.79 | 6.43 | |||||
Net Income Margin % | 5.72 | 5.38 | 5.7 | 5.75 | 6.41 | |||||
Net Avail. For Common Margin % | 5.72 | 5.38 | 5.7 | 5.75 | 6.41 | |||||
Normalized Net Income Margin | 4.25 | 4.4 | 4.64 | 4.82 | 5.12 | |||||
Levered Free Cash Flow Margin | 1.68 | 3.1 | 3.93 | -1.68 | -0.67 | |||||
Unlevered Free Cash Flow Margin | 1.73 | 3.15 | 3.99 | -1.56 | -0.55 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.76 | 1.83 | 1.92 | 1.6 | 1.65 | |||||
Fixed Assets Turnover | 9.48 | 11.08 | 13.01 | 11.56 | 8.05 | |||||
Receivables Turnover (Average Receivables) | 5.9 | 5.81 | 6.01 | 5.45 | 5.92 | |||||
Inventory Turnover (Average Inventory) | 9.81 | 11.47 | 10.77 | 9.09 | 10.76 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.53 | 1.47 | 1.46 | 1.61 | 1.44 | |||||
Quick Ratio | 1.06 | 1.05 | 0.95 | 1.21 | 1.05 | |||||
Operating Cash Flow to Current Liabilities | 0.21 | 0.23 | 0.23 | 0.13 | 0.35 | |||||
Days Sales Outstanding (Average Receivables) | 62.02 | 62.81 | 60.7 | 66.93 | 61.8 | |||||
Days Outstanding Inventory (Average Inventory) | 37.32 | 31.83 | 33.9 | 40.17 | 34.02 | |||||
Average Days Payable Outstanding | 67.22 | 65.8 | 63.39 | 69.66 | 59.36 | |||||
Cash Conversion Cycle (Average Days) | 32.13 | 28.84 | 31.2 | 37.45 | 36.45 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 23.06 | 23.32 | 20.21 | 33.55 | 24.42 | |||||
Total Debt / Total Capital | 18.74 | 18.91 | 16.81 | 25.12 | 19.63 | |||||
LT Debt/Equity | 8.38 | 9.45 | 12.91 | 17.36 | 18.46 | |||||
Long-Term Debt / Total Capital | 6.81 | 7.66 | 10.74 | 13 | 14.83 | |||||
Total Liabilities / Total Assets | 50.64 | 52.81 | 55.59 | 51.5 | 51.69 | |||||
EBIT / Interest Expense | 75.88 | 74.56 | 60.82 | 32.12 | 34.69 | |||||
EBITDA / Interest Expense | 87.21 | 85.66 | 69.41 | 36.93 | 38.92 | |||||
(EBITDA - Capex) / Interest Expense | 77.16 | 73.82 | 62.47 | 19.12 | 0.58 | |||||
Total Debt / EBITDA | 1.03 | 0.94 | 0.73 | 1.4 | 0.99 | |||||
Net Debt / EBITDA | -0.58 | -0.45 | -0.49 | -0.48 | -0.25 | |||||
Total Debt / (EBITDA - Capex) | 1.16 | 1.1 | 0.81 | 2.7 | 66.69 | |||||
Net Debt / (EBITDA - Capex) | -0.65 | -0.52 | -0.54 | -0.93 | -16.46 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 14.09 | 17.97 | 24.16 | -6.99 | 15.68 | |||||
Gross Profit, 1 Yr. Growth % | 9.85 | 21.08 | 25.19 | -1.63 | 20.24 | |||||
EBITDA, 1 Yr. Growth % | 11.11 | 24.08 | 25.96 | -0.58 | 20.86 | |||||
EBITA, 1 Yr. Growth % | 11.63 | 25.04 | 27.34 | -1 | 22.47 | |||||
EBIT, 1 Yr. Growth % | 11.72 | 23.78 | 26.57 | -0.98 | 23.3 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 20.29 | 11.41 | 33.65 | -7.23 | 28.47 | |||||
Net Income, 1 Yr. Growth % | 20.09 | 10.93 | 31.56 | -6.08 | 28.96 | |||||
Normalized Net Income, 1 Yr. Growth % | 10.3 | 21.96 | 30.85 | -3.34 | 23.01 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 19.85 | 10.98 | 30.97 | -8.39 | 24.93 | |||||
Accounts Receivable, 1 Yr. Growth % | 6.81 | 29.36 | 10.76 | -5.15 | 20.67 | |||||
Inventory, 1 Yr. Growth % | -3.24 | 4.4 | 58.59 | -21.71 | 21.14 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -4.27 | 6.41 | 5.18 | 4.11 | 125.77 | |||||
Total Assets, 1 Yr. Growth % | 9.23 | 17.35 | 18.69 | 5.87 | 17.83 | |||||
Tangible Book Value, 1 Yr. Growth % | 11.31 | 5.31 | 12.73 | 17.43 | 18.74 | |||||
Common Equity, 1 Yr. Growth % | 11.16 | 9.67 | 11.75 | 16.59 | 17.62 | |||||
Cash From Operations, 1 Yr. Growth % | 14.15 | 29.41 | 22.59 | -49.1 | 222.45 | |||||
Capital Expenditures, 1 Yr. Growth % | -12.64 | 48.56 | -9.11 | 381.03 | 145.82 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -37.67 | 117.51 | 57.24 | -126.59 | -53.65 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -37.16 | 115.02 | 57.21 | -124.33 | -59.16 | |||||
Dividend Per Share, 1 Yr. Growth % | 23.08 | 10 | 13.64 | -0.03 | 20 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 11.95 | 16.02 | 21.03 | 7.46 | 3.72 | |||||
Gross Profit, 2 Yr. CAGR % | 12.47 | 15.33 | 23.12 | 10.97 | 8.76 | |||||
EBITDA, 2 Yr. CAGR % | 16.31 | 17.42 | 25.02 | 11.9 | 9.61 | |||||
EBITA, 2 Yr. CAGR % | 16.81 | 18.15 | 26.19 | 12.28 | 10.11 | |||||
EBIT, 2 Yr. CAGR % | 16.45 | 17.6 | 25.17 | 11.95 | 10.5 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 22.27 | 15.76 | 22.02 | 11.35 | 9.17 | |||||
Net Income, 2 Yr. CAGR % | 21.35 | 15.42 | 20.8 | 11.16 | 10.05 | |||||
Normalized Net Income, 2 Yr. CAGR % | 15.13 | 16 | 26.33 | 12.46 | 9.04 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 21.25 | 15.33 | 20.56 | 9.54 | 6.98 | |||||
Accounts Receivable, 2 Yr. CAGR % | 6.48 | 17.54 | 19.7 | 2.5 | 6.99 | |||||
Inventory, 2 Yr. CAGR % | 9.67 | 0.51 | 28.67 | 11.43 | -2.62 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 2.85 | 0.93 | 5.79 | 4.64 | 53.31 | |||||
Total Assets, 2 Yr. CAGR % | 11.56 | 13.22 | 18.02 | 12.1 | 11.69 | |||||
Tangible Book Value, 2 Yr. CAGR % | 11.28 | 8.29 | 8.96 | 15.06 | 18.08 | |||||
Common Equity, 2 Yr. CAGR % | 11.13 | 10.41 | 10.71 | 14.14 | 17.1 | |||||
Cash From Operations, 2 Yr. CAGR % | 35.45 | 21.54 | 25.96 | -21.01 | 28.11 | |||||
Capital Expenditures, 2 Yr. CAGR % | -0.91 | 13.92 | 16.2 | 109.1 | 243.87 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 56.2 | 16.44 | 84.94 | -20.87 | -64.9 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 53.67 | 16.24 | 83.86 | -24.51 | -68.48 | |||||
Dividend Per Share, 2 Yr. CAGR % | 22.86 | 16.35 | 11.8 | 6.58 | 9.54 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 15 | 13.92 | 18.67 | 10.86 | 10.13 | |||||
Gross Profit, 3 Yr. CAGR % | 13.55 | 15.27 | 18.53 | 14.24 | 13.98 | |||||
EBITDA, 3 Yr. CAGR % | 18.44 | 18.85 | 20.2 | 15.82 | 14.81 | |||||
EBITA, 3 Yr. CAGR % | 19.56 | 19.49 | 21.14 | 16.38 | 15.58 | |||||
EBIT, 3 Yr. CAGR % | 19.32 | 18.84 | 20.52 | 15.76 | 15.61 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 27.4 | 18.53 | 21.44 | 11.37 | 16.79 | |||||
Net Income, 3 Yr. CAGR % | 27.51 | 17.77 | 20.57 | 11.08 | 16.8 | |||||
Normalized Net Income, 3 Yr. CAGR % | 22.75 | 17.37 | 20.76 | 15.54 | 15.87 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 23.8 | 17.72 | 20.32 | 10.02 | 14.44 | |||||
Accounts Receivable, 3 Yr. CAGR % | 16 | 13.62 | 15.24 | 10.77 | 8.23 | |||||
Inventory, 3 Yr. CAGR % | 8.68 | 7.88 | 17.01 | 9.03 | 14.57 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 3.17 | 4.03 | 2.33 | 5.23 | 35.21 | |||||
Total Assets, 3 Yr. CAGR % | 13 | 13.46 | 15.01 | 13.82 | 13.98 | |||||
Tangible Book Value, 3 Yr. CAGR % | 11.8 | 9.26 | 9.75 | 11.71 | 16.27 | |||||
Common Equity, 3 Yr. CAGR % | 11.78 | 10.65 | 10.86 | 12.63 | 15.29 | |||||
Cash From Operations, 3 Yr. CAGR % | 34.56 | 33.41 | 21.89 | -6.88 | 26.24 | |||||
Capital Expenditures, 3 Yr. CAGR % | -17.44 | 13.41 | 5.66 | 86.58 | 120.68 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 36.79 | 74.42 | 28.7 | 10.84 | -33.8 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 41.26 | 71.88 | 28.55 | 7.01 | -38.49 | |||||
Dividend Per Share, 3 Yr. CAGR % | 23.96 | 18.41 | 15.44 | 7.71 | 10.89 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 13.65 | 13.52 | 17.37 | 11.29 | 12.45 | |||||
Gross Profit, 5 Yr. CAGR % | 12.06 | 12.29 | 17.29 | 13.53 | 14.52 | |||||
EBITDA, 5 Yr. CAGR % | 14.06 | 13.79 | 21.03 | 16.02 | 15.85 | |||||
EBITA, 5 Yr. CAGR % | 14.19 | 13.75 | 22.17 | 16.55 | 16.6 | |||||
EBIT, 5 Yr. CAGR % | 14.05 | 13.38 | 21.62 | 16.03 | 16.4 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 16.57 | 13.82 | 25.22 | 15.61 | 16.38 | |||||
Net Income, 5 Yr. CAGR % | 16.64 | 13.78 | 24.79 | 15.08 | 16.25 | |||||
Normalized Net Income, 5 Yr. CAGR % | 14.74 | 15.24 | 24.18 | 15.38 | 15.92 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 14.53 | 11.69 | 22.5 | 14.38 | 14.8 | |||||
Accounts Receivable, 5 Yr. CAGR % | 12.84 | 18.78 | 17.47 | 9.03 | 11.86 | |||||
Inventory, 5 Yr. CAGR % | 12.5 | 5.18 | 16.28 | 9.29 | 8.73 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 7.22 | 4.83 | 4.21 | 4.27 | 20.29 | |||||
Total Assets, 5 Yr. CAGR % | 13.82 | 13.66 | 14.98 | 12.91 | 13.67 | |||||
Tangible Book Value, 5 Yr. CAGR % | 12.2 | 11.68 | 10.66 | 11.55 | 13.01 | |||||
Common Equity, 5 Yr. CAGR % | 12.25 | 12.64 | 11.35 | 12.03 | 13.31 | |||||
Cash From Operations, 5 Yr. CAGR % | 23.09 | 8.42 | 31.05 | 8.18 | 24.34 | |||||
Capital Expenditures, 5 Yr. CAGR % | -15.31 | -9.61 | -5.35 | 44.85 | 69.4 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 10.76 | 9.17 | 54.33 | 27.14 | -17.02 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 12.01 | 9.18 | 56.97 | 23.67 | -20.66 | |||||
Dividend Per Share, 5 Yr. CAGR % | 15.91 | 11.97 | 18.95 | 13.53 | 13.05 |
- Stock Market
- Equities
- 5434 Stock
- Financials Topco Scientific Co.,Ltd.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition